Skip to content

Lung ultrasound in the diagnosis, treatment and prognosis of pulmonary lesions of novel coronavirus pneumonia (COVID-19)

Lung ultrasound in the diagnosis, treatment and prognosis of pulmonary lesions of novel coronavirus pneumonia(COVID-19)

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030114
Enrollment
Unknown
Registered
2020-02-23
Start date
2020-02-24
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia

Interventions

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with severe cases of newly diagnosed novel coronavirus pneumonia, aged over 18 years old, meeting the diagnostic criteria for confirmed cases and patients with severe and critical types in the sixth edition of the diagnosis and treatment program for novel coronavirus pneumonia.

Exclusion criteria

Exclusion criteria: Patients with severe hemodynamic instability, unfavorable to change body position; Patients with severe deformity of the thorax or massive subcutaneous emphysema that cannot be examined by lung ultrasound; Patients who did not check all 10 points of the BLUE-plus regimen.

Design outcomes

Primary

MeasureTime frame
Lung ultrasound;Chest computed tomography (CT);Respiratory and oxygenation indicators;Prognostic indicators (length of stay, mortality);

Countries

China

Contacts

Public ContactZhu Fengxue

Peking University People's Hospital

fxzhu72@163.com+86 13911005275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026